Find Reports
Select Report Type
Reimbursement Review
Displaying 1376 - 1400 of 1426
Please scroll or swipe to the right to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| efanesoctocog alfa | Altuviiio | efanesoctocog alfa | congenital factor VIII deficiency | Active | ST0840-000 | ||||
| belantamab mafodotin, bortezom... | TBC | belantamab mafodotin, bortezomib, dexamethasone | Previously treated multiple myeloma | Active | PC0379-000 | ||||
| belantamab mafodotin, pomalido... | TBC | belantamab mafodotin, pomalidomide, dexamethasone | Previously treated multiple myeloma | Active | PC0380-000 | ||||
| omaveloxolone | Skyclarys | omaveloxolone | Friedreich’s ataxia | Active | SR0864-000 | ||||
| nemolizumab | TBC | nemolizumab | Prurigo nodularis (PN) | Active | SR0861-000 | ||||
| fidaxomicin | N/A | fidaxomicin | Clostridioides difficile infection | Active | SX0754-000 | ||||
| nivolumab | N/A | nivolumab | Hodgkin lymphoma | Active | PX0376-000 | ||||
| naloxagol | N/A | naloxagol | Management of opioid-induced constipation (OIC). | Active | SX0753-000 | ||||
| Esophageal or Gastroesophageal... | Esophageal or Gastroesophageal Junction Cancer | Active | PH0061-000 | ||||||
| NSCLC without actionable oncog... | Non-small Cell Lung Cancer | Merged | PH0059-000 | ||||||
| Multiple Myeloma | Multiple Myeloma | Merged | PH0060-000 | ||||||
| Pharmaceutical Reviews Update ... | |||||||||
| Multiple Myeloma | Multiple Myeloma | Active | PH0068-000 | ||||||
| Philadelphia negative acute ly... | Philadelphia negative acute lymphoblastic leukemia | Active | PH0067-000 | ||||||
| Non-small-cell lung cancer | Non-small-cell lung cancer | Active | PH0065-000 | ||||||
| Endometrial cancer | Endometrial cancer | Merged | PH0066-000 | ||||||
| relugolix, estradiol, and nore... | Myfembree | relugolix, estradiol, and norethindrone acetate | Management of heavy menstrual bleeding associated with uterine fibroids | Active | SR0885-000 | ||||
| osimertinib | Tagrisso | osimertinib | Unresectable (stage III) non-small cell lung cancer | Active | PC0398-000 | ||||
| abemaciclib | Verzenio | abemaciclib | HR-positive, HER2-negative advanced or metastatic breast cancer | Active | PC0400-000 | ||||
| teplizumab | Tzield | teplizumab | Delay onset of Stage 3 Type 1 Diabetes | Active | SR0867-000 | ||||
| abemaciclib | Verzenio | abemaciclib | HR-positive, HER2-negative advanced or metastatic breast cancer | Active | PC0409-000 | ||||
| venetoclax | Venclexta | venetoclax | Mantle cell lymphoma (MCL) | Active | PC0402-00 | ||||
| inavolisib | Itovebi | inavolisib | Advanced or metastatic breast cancer | Active | PC0382-000 | ||||
| pertuzumab | N/A | pertuzumab | HER2+ breast cancer | Active | PX0379-000 | ||||
| cabozantinib | N/A | cabozantinib | Neuroendocrine tumours | Active | PX0378-000 |
Health Technology Review
Displaying 601 - 602 of 602
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 1376 - 1400 of 2138
Please scroll or swipe to the right to view the full content.
Provisional Funding Algorithm
Displaying 76 - 81 of 81